Nicotine metabolism rates may impact success of smoking cessation treatments
A randomized clinical trial of smokers trying to quit found that the effectiveness of particular smoking cessation therapies might relate to how quickly their body metabolizes nicotine. The study...
View ArticleMedication finds new use in sustaining opioid quit success
New research suggests that clonidine, a medication for high blood pressure and attention deficit hyperactivity disorder (ADHD), can enhance buprenorphine’s ability to treat opioid dependence. This...
View Article2015 Avant-Garde Awards offer extraordinary ideas in HIV/AIDS research
Dr. Jacques Normand describes the 2015 NIDA Avant-Garde awards Watch video With proposals ranging from innovative therapies to the development of unique organoid models of the brain, five scientists...
View ArticleNIDA researchers discover further complexity in brain reward circuitry
NIDA scientists have identified new complexities within the brain’s reward circuitry that involves two major chemicals involved in drug addiction -- dopamine and glutamate. Researchers used rodent...
View ArticleNIDA Director Dr. Nora Volkow to Participate in Facebook Chat about TEDMED...
Dr. Nora Volkow - photo courtesy of Sandy Huffaker for TEDMED NIDA Director Dr. Nora Volkow will participate in a LIVE Facebook chat, hosted by TEDMED, on Thursday, February 12, at 1 p.m. EST to...
View ArticleDr. Susan Weiss appointed division director at NIDA
Dr. Susan Weiss Susan R.B. Weiss, Ph.D., has been selected to lead the Division of Extramural Research (DER), a newly formed Division at the National Institute on Drug Abuse (NIDA), part of the...
View ArticleStudy looks at effects of socioeconomic factors on child brain development...
New research suggests that family income, and to a lesser degree parental education, are associated with brain structure differences in children and young adults. Focusing on brain regions critical...
View ArticleResearch shows that teens and adults are uncertain about legalities of...
A NIDA-funded study showed that while parents in the state of Washington are discussing with their children the legalization of recreational marijuana use among adults, they are unsure what is legal...
View ArticleGene variant related to greater difficulty in quitting smoking and earlier...
People with a specific form of the CHRNA5 gene take an average of four years longer to quit smoking and are at greater risk for developing lung cancer four years earlier, compared to smokers without...
View ArticleCarlos Blanco, M.D., Ph.D. to join NIDA as division director
Dr. Carlos Blanco Carlos Blanco, M.D., Ph.D., a leading researcher in the interface between epidemiology and the treatment of addictive disorders, will be joining the National Institute on Drug Abuse...
View ArticleNIDA highlights drug use trends among college-age and young adults in new...
Use of illicit drugs, including marijuana, has been rising steadily among college-aged young adults. In addition, non-medical use of stimulants, including Adderall and Ritalin, has more than doubled...
View ArticleMedication plus ongoing care provided in emergency departments is promising...
New research comparing treatment approaches for opioid dependent patients in emergency departments (ED) suggests that combining the medication buprenorphine with ongoing care is more effective than...
View ArticlePain reliever investigation wins top NIH Addiction Science Award
A project identifying novel compounds that could be used for pain relief was awarded a first place Addiction Science Award at the 2015 Intel International Science and Engineering Fair (ISEF)—the...
View ArticleMethadone maintenance in prison results in treatment retention, lower drug...
Treatment is the Key A new NIDA-funded study shows that, among people incarcerated for six months or less, those who received continued methadone maintenance while imprisoned were more likely to obtain...
View ArticlePrescribing lifesaving naloxone: Addressing attitudes of primary care clinicians
NIDA-funded research exploring barriers to prescribing naloxone, a safe, easy-to-use drug that can prevent opioid overdose deaths, suggests that primary healthcare providers have limited knowledge...
View ArticleNasal spray naloxone one step closer to public availability
Easy to use delivery technology could prevent opioid overdose deaths The National Institute on Drug Abuse (NIDA) is pleased to announce that Adapt Pharma Limited, a partner of Lightlake Therapeutics...
View ArticleEffects of marijuana – with and without alcohol – on driving performance
Using the most sophisticated driving simulator of its kind to mirror real-life situations, new research shows that marijuana use impairs one measure of driving performance. People driving with blood...
View ArticleNIDA announces new awards for early stage investigators
NIDA’s Dr. Joni Rutter describes the 2015 NIDA Avenir Awards The National Institute on Drug Abuse (NIDA) today announced the first six recipients of its two newly developed Avenir Award programs for...
View ArticleNIDA and NIAAA commentary strongly supports brain disease model of addiction
The brain disease model of addiction is strongly supported by scientific evidence, according to a commentary published today in The Lancet Psychiatry by NIDA Director Dr. Nora Volkow and NIAAA...
View ArticleNIDA announces two online resources
The National Institute on Drug Abuse (NIDA) is pleased to announce two online resources - Substance Use in Women and Therapeutic Communities Research Report. Women face unique issues when it comes to...
View Article